Ebb & Flow

Cumberland Pharmaceuticals Inc. is hoping to capitalize on both the market upswing and the June FDA approval of its Caldolor IV ibuprofen to get an IPO out the door.

The last substantial IPO was almost a year and a half ago, when Italian oncology play MolMed S.p.A. (Milan:MLM) raised $85 million in February 2008...